These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36908302)

  • 1. Predictors of COVID-19 severity and outcomes in Indian patients with rheumatic diseases: a prospective cohort study.
    Mathew J; Jain S; Susngi T; Naidu S; Dhir V; Sharma A; Jain S; Sharma SK
    Rheumatol Adv Pract; 2023; 7(1):rkad025. PubMed ID: 36908302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
    Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
    Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronavirus disease 2019 outcomes among patients with rheumatic diseases 6 months into the pandemic.
    Serling-Boyd N; D'Silva KM; Hsu TY; Wallwork R; Fu X; Gravallese EM; Jorge AM; Zhang Y; Choi H; Sparks JA; Wallace ZS
    Ann Rheum Dis; 2021 May; 80(5):660-666. PubMed ID: 33257496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and COVID-19 outcomes in a regional cohort of pediatric patients with rheumatic diseases.
    Clemente D; Udaondo C; de Inocencio J; Nieto JC; Del Río PG; Fernández AG; Palomo JA; Bachiller-Corral J; Lopez Robledillo JC; Millán Longo C; Leon L; Abasolo L; Boteanu A
    Pediatr Rheumatol Online J; 2021 Nov; 19(1):162. PubMed ID: 34838054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases.
    Hasseli R; Mueller-Ladner U; Hoyer BF; Krause A; Lorenz HM; Pfeil A; Richter J; Schäfer M; Schmeiser T; Strangfeld A; Schulze-Koops H; Voll RE; Specker C; Regierer AC
    RMD Open; 2021 Jan; 7(1):. PubMed ID: 33479021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digestive system involvement and clinical outcomes among COVID-19 patients: A retrospective cohort study from Qatar.
    Khan MU; Mushtaq K; Alsoub DH; Iqbal P; Ata F; Chaudhry HS; Iqbal F; Balaraju G; Maslamani MAA; Varughese B; Singh R; Ejji KA; Kaabi SA; Kamel YM; Butt AA
    World J Gastroenterol; 2021 Dec; 27(46):7995-8009. PubMed ID: 35046626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients.
    FAI2R /SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors
    Ann Rheum Dis; 2021 Apr; 80(4):527-538. PubMed ID: 33268442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes.
    Montero F; Martínez-Barrio J; Serrano-Benavente B; González T; Rivera J; Molina Collada J; Castrejón I; Álvaro-Gracia J
    Rheumatol Int; 2020 Oct; 40(10):1593-1598. PubMed ID: 32794113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 Infection and COVID-19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta-Analysis.
    Conway R; Grimshaw AA; Konig MF; Putman M; Duarte-García A; Tseng LY; Cabrera DM; Chock YPE; Degirmenci HB; Duff E; Egeli BH; Graef ER; Gupta A; Harkins P; Hoyer BF; Jayatilleke A; Jin S; Kasia C; Khilnani A; Kilian A; Kim AHJ; Lin CMA; Low C; Proulx L; Sattui SE; Singh N; Sparks JA; Tam H; Ugarte-Gil MF; Ung N; Wang K; Wise LM; Yang Z; Young KJ; Liew JW; Grainger R; Wallace ZS; Hsieh E;
    Arthritis Rheumatol; 2022 May; 74(5):766-775. PubMed ID: 34807517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study.
    Pablos JL; Galindo M; Carmona L; Lledó A; Retuerto M; Blanco R; Gonzalez-Gay MA; Martinez-Lopez D; Castrejón I; Alvaro-Gracia JM; Fernández Fernández D; Mera-Varela A; Manrique-Arija S; Mena Vázquez N; Fernandez-Nebro A; ;
    Ann Rheum Dis; 2020 Dec; 79(12):1544-1549. PubMed ID: 32796045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study.
    Avouac J; Drumez E; Hachulla E; Seror R; Georgin-Lavialle S; El Mahou S; Pertuiset E; Pham T; Marotte H; Servettaz A; Domont F; Chazerain P; Devaux M; Claudepierre P; Langlois V; Mekinian A; Maria ATJ; Banneville B; Fautrel B; Pouchot J; Thomas T; Flipo RM; Richez C; ;
    Lancet Rheumatol; 2021 Jun; 3(6):e419-e426. PubMed ID: 33786454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study.
    Loarce-Martos J; García-Fernández A; López-Gutiérrez F; García-García V; Calvo-Sanz L; Del Bosque-Granero I; Terán-Tinedo MA; Boteanu A; Bachiller-Corral J; Vázquez-Díaz M
    Rheumatol Int; 2020 Dec; 40(12):2015-2021. PubMed ID: 32945944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US 'hot spot'.
    D'Silva KM; Serling-Boyd N; Wallwork R; Hsu T; Fu X; Gravallese EM; Choi HK; Sparks JA; Wallace ZS
    Ann Rheum Dis; 2020 Sep; 79(9):1156-1162. PubMed ID: 32457048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study.
    Md Yusof MY; Arnold J; Saleem B; Vandevelde C; Dass S; Savic S; Vital EM; Emery P
    Lancet Rheumatol; 2023 Feb; 5(2):e88-e98. PubMed ID: 36712951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent post-discharge symptoms after COVID-19 in rheumatic and musculoskeletal diseases.
    Leon L; Perez-Sancristobal I; Madrid A; Lopez-Pedraza L; Colomer JI; Lerma S; Lois P; Mucientes A; Rodriguez-Rodriguez L; Fernandez-Gutierrez B; Abasolo L
    Rheumatol Adv Pract; 2022; 6(1):rkac008. PubMed ID: 35233480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit.
    Suleyman G; Fadel RA; Malette KM; Hammond C; Abdulla H; Entz A; Demertzis Z; Hanna Z; Failla A; Dagher C; Chaudhry Z; Vahia A; Abreu Lanfranco O; Ramesh M; Zervos MJ; Alangaden G; Miller J; Brar I
    JAMA Netw Open; 2020 Jun; 3(6):e2012270. PubMed ID: 32543702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2-specific T-cell responses after COVID-19 recovery in patients with rheumatic diseases on immunosuppressive therapy.
    Lledó A; Retuerto M; Almendro-Vázquez P; Fernández-Ruiz M; Galindo M; Laguna-Goya R; Paz-Artal E; Lalueza A; Aguado JM; Pablos JL
    Semin Arthritis Rheum; 2021 Dec; 51(6):1258-1262. PubMed ID: 34775160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
    Grasselli G; Greco M; Zanella A; Albano G; Antonelli M; Bellani G; Bonanomi E; Cabrini L; Carlesso E; Castelli G; Cattaneo S; Cereda D; Colombo S; Coluccello A; Crescini G; Forastieri Molinari A; Foti G; Fumagalli R; Iotti GA; Langer T; Latronico N; Lorini FL; Mojoli F; Natalini G; Pessina CM; Ranieri VM; Rech R; Scudeller L; Rosano A; Storti E; Thompson BT; Tirani M; Villani PG; Pesenti A; Cecconi M;
    JAMA Intern Med; 2020 Oct; 180(10):1345-1355. PubMed ID: 32667669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of hospitalization in patients with rheumatic disease and COVID-19 in Ireland: data from the COVID-19 global rheumatology alliance registry.
    Conway R; Nikiphorou E; Demetriou CA; Low C; Leamy K; Ryan JG; Kavanagh R; Fraser AD; Carey JJ; O'Connell P; Flood RM; Mullan RH; Kane DJ; Robinson PC; Liew JW; Grainger R; McCarthy GM;
    Rheumatol Adv Pract; 2021; 5(2):rkab031. PubMed ID: 34622123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.